Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Investments   

We are constantly investing in upgrading the production facilities, simplifying the chemical processes with modern purification technologies, and providing for a safe working environment. Our facilities are ISO 14001 and OHSAS 18001 certified.

POLPHARMA has invested more than €150 million in various areas of its activity over the last five years. The main objective of most of these investments within the pharmaceutical and fine chemicals businesses, R&D, logistics, and other fields was to meet the highest international standards and provide the company with adequate conditions for further development.


In the area of fine chemicals we have focused on:

 

  • Consolidation and upgrading the multipurpose facilities to the highest quality standards (especially the API finishing areas)
  • Adjusting all the manufacturing processes to the international environmental requirements (IPPC Directive)
  • Implementation of the Oracle integrated management system for production planning and warehouse management
  • Modernization of the Pilot Plant and R&D laboratories

 

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo